Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback